Skip to main content
Year archive

HYUNDAI PHARMACEUTICAL CO., LTD — 2023 filings

All 28 regulatory filings released by HYUNDAI PHARMACEUTICAL CO., LTD (004310) in 2023, sourced directly from the official regulator.

28 Filings
2023 Period
2023 filings (28)
Filing Released Lang
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release FY 2023
2023-12-26 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-11-22 Korean
[첨부추가]주주총회소집결의
AGM Information
2023-11-06 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2023-11-06 Korean
분기보고서 (2023.08)
Interim / Quarterly Report 9M 2023
2023-10-16 Korean
신탁계약에의한취득상황보고서
Transaction in Own Shares
2023-10-16 Korean
반기보고서 (2023.05)
Interim / Quarterly Report H1 2023
2023-07-17 Korean
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares
2023-07-14 Korean
공정거래자율준수프로그램운영현황(안내공시)
Governance Information
2023-07-14 Korean
주요사항보고서(자기주식취득신탁계약해지결정)
Transaction in Own Shares
2023-06-22 Korean
신탁계약해지결과보고서
Transaction in Own Shares
2023-06-22 Korean
기타시장안내(기업심사위원회 심의대상 제외 결정 안내)
Legal Proceedings Report
2023-06-09 Korean
기타경영사항(자율공시)
Governance Information
2023-06-09 Korean
회계처리기준위반에따른검찰고발등조치
Legal Proceedings Report
2023-05-17 Korean
기타시장안내(상장적격성 실질심사 사유 발생 안내)
Legal Proceedings Report
2023-05-17 Korean
투자판단관련주요경영사항
Legal Proceedings Report
2023-05-12 Korean
단기차입금증가결정
Capital/Financing Update
2023-05-11 Korean
분기보고서 (2023.02)
Interim / Quarterly Report Q1 2023
2023-04-14 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-02-24 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2023-02-24 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-02-16 Korean
사업보고서 (2022.11)
Annual Report FY 2022
2023-02-16 Korean
공정거래자율준수프로그램운영현황(안내공시)
Governance Information
2023-02-08 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release FY 2022
2023-02-08 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2023-02-08 Korean
주주총회소집결의
AGM Information
2023-02-08 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2023-02-08 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release FY 2022
2023-01-11 Korean